XML 56 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Summary of Fair Value Available-for-sale Securities The following table summarizes the Company's financial assets and liabilities, excluding pension assets, disaggregated by the security type, measured at fair value on a recurring basis (in millions):
As of
December 31, 2021Fair Value Level
DescriptionAmortized CostUnrealized gainsUnrealized lossesFair valueLevel 1Level 2
Assets:
Cash and cash equivalents:
Demand and time deposits$19.5 $— $— $19.5 $19.5 $— 
Money market funds0.7 — — 0.7 0.7 — 
Corporate bonds1.6 — — 1.6 — 1.6 
Commercial paper2.0 — — 2.0 — 2.0 
Other current assets:
Corporate bonds$16.0 $— $— $16.0 $— $16.0 
Certificate of deposit1.9 — — 1.9 — 1.9 
Commercial paper5.0 — — 5.0 3.0 2.0 
US Treasury bonds0.4 — — 0.4 — 0.4 
Other assets:
Corporate bonds$19.7 $— $— $19.7 $— $19.7 
US Treasury bonds1.6 — — 1.6 — 1.6 

The investments included in other assets have maturity dates ranging between one and five years.

As of
December 31, 2020Fair Value Level
DescriptionAmortized CostUnrealized gainsUnrealized lossesFair valueLevel 1Level 2
Assets:
Cash and cash equivalents:
Demand and time deposits$8.5 $— $— $8.5 $8.5 $— 
Fair Value, by Balance Sheet Grouping
The carrying amounts and fair value of the Company’s long-term borrowings are as follows (in millions):
As of December 31,
 20212020
 Carrying AmountFair ValueCarrying AmountFair Value
Long-term debt, including current portion (1)
Convertible notes$809.4 $1,696.7 $515.6 $967.1 
Long-term debt2,265.2 2,245.5 2,975.7 2,966.8 
_______________________

(1)Long-term debt is carried on the Consolidated Balance Sheets at historical cost net of debt discount and issuance costs.
Fair Value Measurements, Nonrecurring The following table shows the adjustments to fair value of certain of the Company's non-financial assets that had an impact on the Company's results of operations (in millions):
Year Ended December 31,
202120202019
Nonrecurring fair value measurements
Asset impairments (Level 3)$7.9 $17.5 $3.4 
IPRD impairments (Level 3)2.9 1.3 1.6 
$10.8 $18.8 $5.0